Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer

Clinical trial NCT00146588 · COMPLETED

Trial details

NCT number: NCT00146588
Sponsor: Craig A. Bunnell, MD, MPH
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Breast Cancer Stage I Breast Cancer Stage II Breast Cancer Stage IIIA Breast Cancer

Start date: 2002-04-01
Primary completion: 2004-12-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.